共 7 条
[1]
Janssen, Niemegeers, Awouters, Et al., Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties, J Pharmacol Exp Ther, 244, pp. 685-693, (1988)
[2]
Leysen, Gommeren, Eens, Et al., Biochemical profile of risperidone, a new antipsychotic, J Pharmacol Exp Ther, 247, pp. 661-670, (1988)
[3]
Castelao, Ferreira, Gelders, Et al., The efficacy of the D2 and 5-HT2 antagonist risperidone (R 64 766) in the treatment of chronic psychosis, Schizophrenia Research, 2, pp. 411-415, (1989)
[4]
Meco, Bedini, Bonifati, Et al., Risperidone in the treatment of chronic schizophrenia with tardive dyskinesia, Curr Ther Res, 46, pp. 876-883, (1989)
[5]
Mesotten, Suy, Pietquin, Et al., Therapeutic effect and safety of increasing doses of risperidone (R 64766) in psychotic patients, Psychopharmacology, 99, pp. 445-449, (1989)
[6]
Roose, Gelders, Heylen, Risperidone (R 64 766) in psychotic patients. A first clinical therapeutic exploration, Acta Psychiatr Belg, 88, pp. 233-241, (1988)
[7]
Meert, Awouters, Serotonin 5-HT2 antagonists: A preclinical evaluation of possible therapeutic effects, Serotonin: Sleep and Mental Disorders, (1991)